Topic: Drugs - Primary Care
Monday, 21 November 2016
The mechanisms underlying HF are complex and involve the interaction of many hormonal and molecular signalling pathways. These pathways form the basis of many pharmacological treatments, old and new. This article will examine the factors associated with the development of HF, the pathophysiology behind it and the neurohormonal pathways involved in established HF.
Friday, 28 May 2021
The first of 3 interactive programmes providing practical answers about GLP-1 receptor agonist therapy. Jane Diggle and Mike Cummings discuss the practicalities of effectively initiating GLP-1 receptor agonists in daily practice.